智能制造赋能品牌增长，西子健康递交港股上市申请

Core Viewpoint - Xizi Health has submitted its listing application to the Hong Kong Stock Exchange, marking a significant step in its capital expansion process and aiming for high-quality development in the sports nutrition industry [1] Company Overview - Xizi Health operates as a professional sports nutrition brand operator, focusing on industry trends and developing four core brands: FoYes, fiboo, Gu Ben Ri Ji, and HotRule, creating a diverse product matrix [1] - The product range includes core categories such as protein powder, compound whey protein powder, and creatine, as well as trendy functional foods like functional gummies and coffee, targeting various consumer groups [1] Financial Performance - In the first three quarters of 2023, 2024, and 2025, Xizi Health achieved revenues of 1.447 billion yuan, 1.692 billion yuan, and 1.609 billion yuan respectively, with net profits of 93.856 million yuan, 149 million yuan, and 118 million yuan, indicating steady revenue growth and improving profitability [1] Market Trends - The nutrition and health food market in China is experiencing a golden development period, with the market size projected to grow from 297.9 billion yuan in 2020 to 405.7 billion yuan in 2024, reflecting a compound annual growth rate of 8.0% [2] - Consumer health demands are becoming more diversified and personalized, pushing the industry towards specialization and refinement [2] Manufacturing Capabilities - Xizi Health emphasizes smart manufacturing as a core competitive advantage, establishing a high-standard, intelligent production system to ensure stable product supply and quality [2] - The manufacturing base in Jiangxi has a production area of 19,200 square meters and a flexible capacity of 7.35 million barrels of protein powder, allowing for efficient response to diverse market orders [2] Technological Integration - The manufacturing base integrates advanced technologies such as big data, cloud computing, and AI, achieving a production automation level of 95%, which enhances efficiency and reduces costs while maintaining product quality [4] - The company plans to expand production capacity through new production lines and facilities, aiming for rapid product iteration and stringent cost control [4] Quality Control Initiatives - Xizi Health is committed to building a comprehensive quality management system across the entire supply chain, enhancing consistency in quality from procurement to delivery [4]